Literature DB >> 6123567

A novel conjugate as a major metabolite of bromperidol in man.

D R Hawkins, S R Biggs, R R Brodie, L F Chasseaud, I Midgley.   

Abstract

The major urine metabolites of the neuroleptic drug, bromperidol, after oral doses to rats and dogs are p-fluorophenylacetic acid and its glycine conjugate resulting from oxidative N-dealkylation. While the same metabolites were also detected in human urine, also present was a major unknown component representing 50% of the total urine metabolites, which apparently was not formed by rats and dogs to any extent. Mass spectroscopic investigations a substituent attached to the tertiary hydroxyl group. The mass spectrum of the metabolite after trifluoroacetylation was consistent with an O-glucofuranosiduronolactone conjugate of bromperidol.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6123567     DOI: 10.1111/j.2042-7158.1982.tb04711.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  1 in total

Review 1.  Bromperidol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in psychoses.

Authors:  P Benfield; A Ward; B G Clark; S G Jue
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.